184 related articles for article (PubMed ID: 34938663)
21. A high sIL-2R/ferritin ratio is a useful marker for the diagnosis of lymphoma-associated hemophagocytic syndrome.
Tsuji T; Hirano T; Yamasaki H; Tsuji M; Tsuda H
Ann Hematol; 2014 May; 93(5):821-6. PubMed ID: 24705932
[TBL] [Abstract][Full Text] [Related]
22. Clinical characteristics of T-cell lymphoma associated with hemophagocytic syndrome: comparison of T-cell lymphoma with and without hemophagocytic syndrome.
Tong H; Ren Y; Liu H; Xiao F; Mai W; Meng H; Qian W; Huang J; Mao L; Tong Y; Wang L; Qian J; Jin J
Leuk Lymphoma; 2008 Jan; 49(1):81-7. PubMed ID: 18203016
[TBL] [Abstract][Full Text] [Related]
23. [Lymphoma-associated hemophagocytic syndrome(LAHS)].
Takahashi N
Nihon Rinsho; 2000 Mar; 58(3):665-8. PubMed ID: 10741143
[TBL] [Abstract][Full Text] [Related]
24. Elevated serum adenosine deaminase levels in secondary hemophagocytic lymphohistiocytosis.
Chen W; Zhang S; Zhang W; Yang X; Xu J; Qiu H; Zhang X; Li J
Int J Lab Hematol; 2015 Aug; 37(4):544-50. PubMed ID: 25764155
[TBL] [Abstract][Full Text] [Related]
25. Profiling and bioinformatics analyses reveal differential circular RNA expression in NK/T-cell lymphoma-associated hemophagocytic syndrome.
Man C; Fan Y; Yin G; Huang J; Wang J; Qiu H
Biosci Rep; 2020 Sep; 40(9):. PubMed ID: 32856037
[TBL] [Abstract][Full Text] [Related]
26. Aggressive diffuse large B-cell lymphoma with hemophagocytic lymphohistiocytosis: report of one case.
Tang S; Zhao C; Chen W
Int J Clin Exp Pathol; 2020; 13(9):2392-2396. PubMed ID: 33042349
[TBL] [Abstract][Full Text] [Related]
27. Adult onset haemophagocytic lymphohistiocytosis prognosis is affected by underlying disease: analysis of a single-institution series of 174 patients.
Zhang Q; Li L; Zhu L; Zhu J; Yang X; Zhou D; Zheng Y; Zhu M; Xie M; Sun J; Li X; Wu Y; Wei Z; Xie W; Ye X
Swiss Med Wkly; 2018 Sep; 148():w14641. PubMed ID: 30378643
[TBL] [Abstract][Full Text] [Related]
28. Clinical features and prognostic analysis of lymphoma-associated hemophagocytic syndrome: A report of 139 cases.
Zhang Q; Wang L; Zhou D; Zhu L; Li L; Xie W; Tan Y; Ye X
Oncol Lett; 2023 Jan; 25(1):13. PubMed ID: 36478898
[TBL] [Abstract][Full Text] [Related]
29. Ruxolitinib combined with doxorubicin, etoposide, and dexamethasone for the treatment of the lymphoma-associated hemophagocytic syndrome.
Zhou L; Liu Y; Wen Z; Yang S; Li M; Zhu Q; Qiu S; Gao Y; Wang H; Yuan Y; Zhang H; Chen C; Zeng W; Guan Z; Pan X
J Cancer Res Clin Oncol; 2020 Nov; 146(11):3063-3074. PubMed ID: 32617699
[TBL] [Abstract][Full Text] [Related]
30. The Prognostic Significance of Beta2 Microglobulin in Patients with Hemophagocytic Lymphohistiocytosis.
Jiang T; Ding X; Lu W
Dis Markers; 2016; 2016():1523959. PubMed ID: 27110054
[TBL] [Abstract][Full Text] [Related]
31. Clinical analysis and prognostic significance of lymphoma-associated hemophagocytosis in peripheral T cell lymphoma.
Xie W; Hu K; Xu F; Zhou D; He J; Shi J; Luo Y; Zhu J; Zhang J; Lin M; Ye X; Huang H; Cai Z
Ann Hematol; 2013 Apr; 92(4):481-6. PubMed ID: 23238896
[TBL] [Abstract][Full Text] [Related]
32. Lymphoma-associated hemophagocytic syndrome: clinical features and treatment outcome.
Han AR; Lee HR; Park BB; Hwang IG; Park S; Lee SC; Kim K; Lim HY; Ko YH; Kim SH; Kim WS
Ann Hematol; 2007 Jul; 86(7):493-8. PubMed ID: 17347847
[TBL] [Abstract][Full Text] [Related]
33. IP-10/CXCL10 and MIG/CXCL9 as novel markers for the diagnosis of lymphoma-associated hemophagocytic syndrome.
Maruoka H; Inoue D; Takiuchi Y; Nagano S; Arima H; Tabata S; Matsushita A; Ishikawa T; Oita T; Takahashi T
Ann Hematol; 2014 Mar; 93(3):393-401. PubMed ID: 23975214
[TBL] [Abstract][Full Text] [Related]
34. [Clinical Characteristics and Prognostic Factors of Children with Non-Hodgkin's Lymphoma of Different Pathological Subtypes].
Zheng YZ; Chen ZS; Hua XL; Zheng H; LE SH; Li J; Hu JD
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Apr; 28(2):500-506. PubMed ID: 32319386
[TBL] [Abstract][Full Text] [Related]
35. A clinical study of 21 patients with hemophagocytic syndrome in 295 cases diagnosed with nasal type, extranodal nature killer/T cell lymphoma.
Li N; Zhang L; Liu J; Zhang J; Weng HW; Zhuo HY; Zou LQ
Cancer Biol Ther; 2017 Apr; 18(4):252-256. PubMed ID: 28278074
[TBL] [Abstract][Full Text] [Related]
36. Epstein-Barr virus-associated extranodal non-Hodgkin's lymphoma of the sinonasal tract and nasopharynx in Thailand.
Mitarnun W; Suwiwat S; Pradutkanchana J
Asian Pac J Cancer Prev; 2006; 7(1):91-4. PubMed ID: 16629523
[TBL] [Abstract][Full Text] [Related]
37. Epstein-Barr virus genome in non-Hodgkin's lymphomas occurring in immunocompetent patients: highest prevalence in nonlymphoblastic T-cell lymphoma and correlation with a poor prognosis. Danish Lymphoma Study Group, LYFO.
d'Amore F; Johansen P; Houmand A; Weisenburger DD; Mortensen LS
Blood; 1996 Feb; 87(3):1045-55. PubMed ID: 8562929
[TBL] [Abstract][Full Text] [Related]
38. [Effect of Complicated Hemophagocytic Syndrome on Clinical Prognosis of Patients with Non-Hodgkin's Lymphoma and Analysis of Its Affecting Factors].
Lin JF; Zeng ZY; Yang AP; Zheng L; Chen JM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Aug; 25(4):1042-1046. PubMed ID: 28823265
[TBL] [Abstract][Full Text] [Related]
39. Hemophagocytic Lymphohistiocytosis as the Presenting Manifestation of Relapsed Classic Hodgkin's Lymphoma in the Presence of Concurrent Human Immunodeficiency Virus, Genital Herpes, Epstein-Barr Virus and Mycobacterium Avium Complex Infection.
Siddiqui RS; Agladze M; Bashir T
Cureus; 2020 Nov; 12(11):e11563. PubMed ID: 33364090
[TBL] [Abstract][Full Text] [Related]
40. Clinical features and survival of extranodal natural killer/T cell lymphoma with and without hemophagocytic syndrome.
Jia J; Song Y; Lin N; Liu W; Ping L; Zheng W; Wang X; Xie Y; Tu M; Zhang C; Ying Z; Deng L; Ding N; Zhu J
Ann Hematol; 2016 Dec; 95(12):2023-2031. PubMed ID: 27595760
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
